(Q45784287)

16 December 2017

title

Effect of anti-V3 antibodies on cell-free and cell-to-cell human immunodeficiency virus transmission (English)

1 reference

16 December 2017

1 reference

1 reference

7

Fauci AS

1 reference

16 December 2017

1

Pantaleo G

1 reference

16 December 2017

author name string

Demarest JF

2

1 reference

16 December 2017

Vaccarezza M

3

1 reference

16 December 2017

Graziosi C

4

1 reference

16 December 2017

Bansal GP

5

1 reference

16 December 2017

Koenig S

6

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 January 1995

1 reference

16 December 2017

European Journal of Immunology

published in

1 reference

16 December 2017

volume

25

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

226-231

1 reference

16 December 2017

Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Variable and conserved neutralization antigens of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Identification of Conserved Residues in the Human Immunodeficiency Virus Type 1 Principal Neutralizing Determinant That Are Involved in Fusion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Neutralizing monoclonal antibodies to the AIDS virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Peptide component vaccine engineering: targeting the AIDS virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Specificity and function of the individual amino acids of an important determinant of human immunodeficiency virus type 1 that induces neutralizing activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Potential mechanisms for the cytopathic properties of HIV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Lymphoid organs function as major reservoirs for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

The immunopathogenesis of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Retroviral infection of accessory cells and the immunological paradox in AIDS

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Antibody-mediated clearance of alphavirus infection from neurons

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830250137

7 January 2021

Identifiers

DOI

10.1002/EJI.1830250137

1 reference

16 December 2017

PubMed ID

7843235

1 reference

16 December 2017